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ABSTRACT 
BACKGROUNDS: 
Magnesium is a well known inhibitor of catecholamine release. This study 
investigates whether i.v., magnesium sulphate attenuates the hemodynamic 
response to pneumoperitoneum during laparoscopic surgeries by changing the 
neurohumoral responses. 
 
METHODS: 
In a randomised, double blind control study, 60 patients of both sexes were 
chosen. 30 patients in the study group received i.v., magnesium sulphate 50 
mg/kg, 1 minute before pneumoperitoneum and 30 patients in the control group 
received normal saline. Perioperative anaesthetic care was standardised in all 
patients. Intraoperative heart rate and blood pressure was monitored. 
 
RESULTS: 
Systolic and diastolic blood pressure and heart rate was significantly higher in 
the control group when compared to the study group. 
 
CONCLUSION: 
Intravenous magnesium sulphate attenuates the arterial pressure increase during 
laparoscopic surgeries. 
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INTRODUCTION 
 
“The cleaner and gentler the act of operation, the less pain the patient 
suffers, the smoother and quicker the convalescence, the more exquisite his 
healed wound, the happier his memory of the whole incident” 
- Lord Moynihar ( 1920 ) 
 
The rising popularity of laparoscopic surgery is one of the most spectacular 
events in modern surgical history, putting an end to the era of ‘ Big surgeons 
Big incisions ‘ 
 
HISTORY 
The history of laparoscopic revolution can be traced back to the tenth century 
A.D. The Arabian physician Abulkasim (936 -1013 AD) is often credited with 
being the first to use reflected light to inspect an internal organ, the cervix. 
 
Subsequently instruments were developed and the early pioneers introduced 
trochars and cystoscopes directly into the peritoneal cavity. At the turn of the 
20th century, George Kelling of Dresden used a cystoscope to observe the 
abdominal organs in dogs. He realised pneumoperitoneum was very essential 
for exposure and therefore used room air for insufflations of the peritoneal 
cavity. He then coined the term “celioscopy” to describe the technique. 
6 
 
 
The Swedish physician Hans Christian Jacobaeus in 1910 first used this 
procedure in man. He also coined the term “laparoscopy”. Earlier procedures 
were entirely diagnostic. 
 
Goetz and later Veress developed a spring loaded insufflation needle for safe 
creation of pneumoperitoneum. Air was the first gas to be used for 
pneumoperitoneum. It was cheap and easily available. Later oxygen was also 
used. However both these gases support combustion and have a potential for gas 
embolism because of poor Ostwald’s blood gas solubility coefficient (0.006, 
0.013). 
 
In 1970s, nitrous oxide was used by gynaecologists because of its low cost and 
high turnover. However it supports combustion if mixed with methane from the 
bowel. 
 
In 1924, Richard Zollikofer promoted the use of carbondioxide. It is relatively 
inert, readily absorbed by peritoneal membrane (blood/gas solubility 0.48) and 
is readily exhaled via the lung. It has now become the standard gas for 
pneumoperitoneum. 
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Other alternative gases like helium, xenon and argon are inert and expensive 
and have very low blood gas solubility (0.00018) and therefore high chances of 
gas embolism. 
 
Raoul Palmer in Paris stressed the importance of monitoring intra-abdominal 
pressure. It was Kurt Semm of Germany, who developed an automatic 
insufflations device, that measured intra-abdominal pressure and gas flow. 
Before that syringes were used to insufflate air into the peritoneal cavity. 
 
LAPAROSCOPIC SURGERIES: 
 
Although in 1985, Erich Muhe of Germany first described his technique of 
laparoscopic cholecystectomy in humans using a galloscope, it was in 1987 that 
the complete removal of a diseased gall bladder in a patient was performed by 
Mouret in Lyon, France. 
 
Diminished pain and cosmetic disfigurement as well as quicker resumption of 
normal activities has increased its acceptance nowadays. Initially it was done 
for short gynaecological diagnostic procedures. However as more and more 
patients are being referred for surgery, now they are conducted in older and high 
risk patients who were previously considered unfit for laparotomy. 
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After the widespread use of laparoscopic intraperitoneal approach for 
appendicectomy and cholecystectomy, it is now being used for a variety of 
extraperitoneal surgeries, including inguinal hernia surgeries, adrenal and renal 
surgeries. The extraperitoneal insufflations of carbondioxide has a risk of 
increased carbondioxide absorption.  
 
Extremes of patient positioning, insufflations of exogenous gases and increased 
intra-abdominal pressure pose a severe strain on the patient’s physiology. The 
anaesthesiologist should be aware of these changes and the possible 
complications, so that early detection and prompt treatment may be instituted. 
 
The rapid development in the field of laparoscopic surgeries and the inclusion 
of high risk patients would not have been possible without a concurrent advance 
in the anaesthetic drugs and techniques. Advances in laparoscopic surgeries has 
been associated with parallel development in anaesthetic approaches. The 
anaesthesiologist must constantly improvise and evolve his approach in the face 
of a never ending domain of laparoscopic surgery.  
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PATHOPHYSIOLOGY OF PNEUMOPERITONEUM: 
 
Upto intra abdominal pressure of 15 mm Hg the cardiac output does not change 
significantly. The mean arterial pressure may rise initially  but thereafter 
normalises or decreases. Heart rate may also  rise transiently. Joris et al 
observed a significant increase in systemic vascular resistance (65%) and 
pulmonary vascular resistance (90%) and a decrease in cardiac index (20%) 
while the pulmonary capillary wedge pressure and central venous pressure 
increased. 
 
Pneumoperitoneum leads to cephalad shift of diaphragm, reduced lung 
expansion, reduced diaphragmatic excursion causing pattern of restrictive lung 
disease. There is a fall in functional residual capacity, tidal volume and minute 
ventilation. Pulmonary vascular resistance increases, uneven distribution of 
ventilation to non dependent parts of the lung produces ventilation perfusion 
mismatch, hypoxia and hypercarbia. 
 
Oliguria (urine output < 0.5ml/kg) has been usually seen. As IAP increases, the 
compression of renal vasculature, the renal parenchyma and the inferior vena 
cava leads to decreased renal blood flow, cortical and medullary perfusion and 
renal venous outflow. Apart from renal compression there is a release of 
neurohormonal factors as renin, aldosterone, endothelin and anti-diuretic 
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hormone resulting in systemic vasoconstriction and fluid retention. Regional 
blood flow to all intra-abdominal organs including hepatic, mesenteric, 
intestinal mucosa, stomach, duodenum, pancreas and spleen is reduced as IAP 
approaches 15 mm Hg. However the blood flow to the adrenal glands is 
preserved. 
 
Hepatic perfusion has a unique autoregulatory mechanism known as “hepatic 
arterial buffer response(HABR)”. Richter et al demonstrated a loss of this 
response at an IAP of 12 – 15 mm Hg. Impairment of microcirculation occurs 
with pressures as low as 15 mm Hg and within a short interval (60 min.). 
 
Rise in IAP compresses inferior vena cava and increases lumbar spinal pressure 
by reducing drainage from lumbar plexus, thereby increasing intracranial 
pressure and intraocular pressure. Raised intra-abdominal pressure results in 
increased cerebral blood flow.  Hypercapnia associated with laparoscopy further 
produces reflex vasodilatation in the central nervous system attributing to 
increased intracranial pressure. 
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PHYSICAL PROPERTIES OF THE COMMON 
INSUFFLATION GASES 
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CARBON DIOXIDE: 
 
It is the insufflating agent of choice nowadays. It is relatively inert, readily 
absorbed, non combustible and cheap.  It is used from either central pipelines or 
cylinders.  It is highly soluble with a solubility coefficient of 0.48  at  37C. The 
rate of absortion of any gas depends on its solubility, absorption area, the 
pressure gradient across the membrane and the diffusion constant. The rate 
limiting factor for carbon dioxide absorption is local perfusion. But the surface 
area and the IAP also play a significant role. CO₂ is readily absorbed from the 
peritoneum, passes through the portal and systemic circulation and is readily 
excreted through the lungs.  
  
It is carried in blood in three forms: 90% in the form of bicarbonate, 5 – 10% 
dissolved in plasma and the rest is combined with protein, mainly haemoglobin.  
 
The increase in PaCO₂   was first demonstrated in 1969 in a group of patients 
undergoing pelvic laparoscopy using   CO₂  insufflations, under   halothane 
anaesthesia, using volume limited constant minute volume ventilation. This 
effect was not seen during the use of other insufflating gases and hence was 
thought to be due to the absorption of the gas from the peritoneum.  During  
carboperitoneum the CO₂    excretion increased, but the oxygen consumption 
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remained stable indicating that the increase in CO₂    is not due to 
hypermetabolism. Although permissive hypercapnia is used as a treatment 
modality in certain medical conditions, maintaining normocapnia is important 
during laparoscopic surgeries.  
 
Absorption of carbondioxide during pneumoperitoneum causes minimal 
hypercarbia and acidosis. Mild hypercarbia ( PaCO₂ of 45 – 50 mmHg ) does 
not cause significant hemodynamic changes. While severe hypercarbia  ( PaCO₂ 
of 50 - 60 mmHg )  has an impact on the cardiovascular system causing 
vasoconstriction, tachycardia and even arrhythmias. The increase in IAP is the 
factor mainly responsible for the increase in catecholamines. 
 
Marathe first demonstrated that despite a significant increase in the PaCO₂, the 
cardiovascular changes occurred only when the levels increased 33 percent 
above the baseline. This discrepancy suggests that the deleterious hemodynamic 
changes that occur during  pneumoperitoneum are either due to a long duration 
of  CO₂  insufflations or high intra-abdominal pressure.  
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PHYSIOLOGICAL EFFECTS OF CARBON DIOXIDE: 
Carbon dioxide has a major regulatory effect in the control of respiration by 
both the central and peripheral mechanisms. It readily crosses the blood brain 
barrier, forms carbonic acid and dissociates into H⁺ ions which acts on the 
chemosensitive area in the ventral medulla. Activation of this area results in 
stimulation of inspiratory centre and increase in respiratory rate. Hypercarbia 
can also cause hypoxic pulmonary vasoconstriction and lead to increased 
pulmonary resistance, which could cause a right ventricular stress in a poorly 
compensated heart.  
 
The cardiovascular effects of carbon dioxide are balanced between its direct 
cardiodepressant effects and stimulatory effects. High levels of carbon dioxide 
will cause release of catecholamines due to sympathetic system activation. This 
causes an increase in cardiac output, heart rate, stroke volume and contractility. 
On the other hand, the acidosis caused by hypercarbia has a direct myocardial 
depressant effect. Cardiac conduction disturbances are also known to occur.  
 
Hypercarbia causes an increase in the cerebral blood flow. For every 1 mmHg 
increase in PaCO₂ the CBF increases by 1.8 ml / 100 g / min. The CBF doubles 
as the  PaCO₂  increases from 40 to 80 mmHg. This could be disastrous in 
patients with intracranial lesions.     
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CARBOPERITONEUM RELATED COMPLICATIONS: 
Hypercarbia is the main reason for carboperitoneum related complications. 
Hypercarbia causes an increase in the mean pulmonary arterial pressure and 
pulmonary hypertension. The reflex vasodilatation causes an increased cerebral 
blood flow and increase the ICP. It has the least effect on hepatic blood flow 
and renal blood flow.  
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INTRA ABDOMINAL PRESSURE: 
Abdomen is a closed space bounded by the diaphragm, costal margins, the 
contracting abdominal muscles and containing the intestines. There is a steady 
pressure within the closed abdominal cavity. The normal intra-abdominal 
pressure is 0 to 5 mmHg. When the values are more than 12 mmHg, the IAP is 
said to be high. 
 
Depending on the level of IAP the pathophysiological changes in the body vary 
during laparoscopic surgeries.  The IAP can be classified as low ( 7 to 11 
mmHg ) , standard ( 12 to 15 mmHg ) and high ( >15 mmHg ) during 
pneumoperitoneum. 
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PHYSIOLOGICAL EFFECTS OF LOW IAP: (7 – 11 mmHg ) 
Upto a pressure of 10 mmHg, there are no significant hemodynamic and 
metabolic changes. But the hepatic blood flow, portal venous circulation and 
microvascular circulation are all affected even at a pressure of 10 mmHg. 
Postoperative liver dysfunction and elevation of liver enzymes have been 
documented when IAP is as low as 10 mmHg. The advantages include lesser 
incidence of shoulder pain, lower pain scores and lesser postoperative nausea 
and vomiting in the low pressure group compared to the standard pressure 
group.  
 
PHYSIOLOGICAL EFFECTS OF STANDARD IAP: ( 12 – 15 
mmHg ) 
 
The cardiac output does not decrease significantly at an IAP of 15 mmHg. 
There is an increase in the afterload and a reduction in stroke volume due to the 
depression of the myocardium by carbon dioxide.  The venous return actually 
increases due to the compression of the capacitance vessels rather than collapse. 
But there is a diminished flow velocity in the femoral vein causing stagnation of 
blood flow and increased risk of venous thromboembolism.  
 
The mean arterial pressure ( MAP ) increases transiently due to shunting of 
blood away from the peritoneal cavity, but normalises later. The heart rate also 
increases transiently as a compensatory response to maintain the cardiac output 
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but there is no long term change in the heart rate. Sometimes bradycardia and 
asystole also have been reported. The possible mechanism could be direct 
stimulation of vagus and increase in parasympathetic discharge.  
 
Pneumoperitoneum at standard IAP affects the pulmonary function also. Due to 
the upward shift of the diaphragm, there is a decrease in the lung expansion and 
the capacities of the lung and an increase in the pulmonary vascular resistance. 
Mismatch between the ventilation and perfusion occurs and leads to increased 
incidence of hypoxia and hypercarbia.  
 
IAP of 15 mmHg causes compression of the renal vessels and a decrease in 
urine output. Regional blood flow to all intra-abdominal organs get decreased. 
Raised intra-abdominal pressure can increase the lumbar spinal pressure and 
lead to increased intracranial and intraocular pressures.  
 
PHYSIOLOGICAL EFFECTS OF HIGH IAP: ( > 15 mmHg ) 
When the IAP approaches 20 mmHg, there is a compression of the inferior vena 
cava leading to decreased venous return and a deleterious decrease in the 
cardiac output. The increased systemic vascular resistance, high intrathoracic 
pressure all lead to further fall in cardiac output. Keskin A et al has shown that 
at an IAP of 20 mmHg there is a decrease in the myocardial oxygen extraction, 
lactate extraction and ATP production. This altered myocardial metabolism 
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leads to deterioration of the cardiac contractility. The pulmonary capillary 
wedge pressure, CVP and left sided filling pressure is all increased at an IAP of 
15 to 20 mmHg. 
 
High IAP leads to an increase in the peak airway pressures and the plateau 
pressures. As in the standard IAP, a reduction in functional residual capacity 
causes ventilation perfusion mismatch and leads to hypoxia. Ventilation with 
PEEP ( positive end expiratory pressure ) improves the gas exchange and 
oxygenation. But the presence of PEEP could increase the intrathoracic pressure 
and cause further fall in cardiac output. Therefore PEEP should be applied with 
caution.  A modern ventilation technique uses the ‘ alveolar recruitment 
strategy’ which consists of manual ventilation to an airway pressure of 40 
mmHg for 10 breaths per minute , followed by the usual mechanical ventilation 
with mild PEEP of 5 cm H₂O.  
 
At an IAP of > 20 mmHg there is a significant decrease in portal venous blood 
flow and liver dysfunction. Renal hypoperfusion is also significant and leads to 
acute tubular necrosis and anuria. There is a rise in serum potassium levels but 
it does not reach levels that would be clinically harmful.  Some prophylactic 
measures have been suggested to prevent acute tubular necrosis. They include a 
renal dose of dopamine infusion ( 1 – 3 mcg/kg/min ) and warm insufflations of 
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carbon dioxide. Blunting of the pressor responses using β – blockers, α₂ - 
agonists, lignocaine or other drugs could decrease the renal ischaemia.  
 
Though the high IAP could result in a better surgical exposure, better access to 
the abdominal organs and a safe surgical approach, the adverse hemodynamic 
consequences, pulmonary and hepatorenal dysfunction and higher incidence of 
PONV  may  lead to increased postoperative morbidity. 
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GASLESS LAPAROSCOPY: 
 
In case of elderly patients with cardiorespiratory  compromise another method 
of creating working space in the abdomen is used. In this , the abdominal 
integument is lifted ( laparolift or laparotensor ) without using any gas. The 
anterior abdominal wall is elevated to 10 – 15 cm using a mechanical retractor. 
Since the intra-abdominal pressure is not elevated there is no absorption of 
carbon dioxide and this technique causes negligible effects on the 
cardiovascular, respiratory and renal systems.  
 
Some surgeons use a 4 mmHg of pneumoperitoneum in addition to the lifting of 
the abdominal wall. However due to the increased technical difficulty, increased 
operating time and lack of benefit with regard to postoperative nausea and 
vomiting it did not gain much popularity.   
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HEMODYNAMIC EFFECTS OF 
PNEUMOPERITONEUM: 
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The extent of cardiovascular changes depend on the intra-abdominal pressure, 
patient position, carbondioxide absorption, ventilator strategy and surgical 
technique and nature and duration of the procedure. The patient’s intravascular 
volume, pre-existing cardiopulmonary status, depth of anaesthesia, anaesthetic 
agent used, neurohormonal factors and perhaps patient medication all influence 
the cardiovascular responses to the creation of pneumoperitoneum and 
laparoscopy. The combined effect of all these factors manifest in a given 
patient. The intraperitoneal pressure and the type of gas used have the 
predominant effect in the cardiovascular changes with the other factors 
modulating these effects. It is difficult to differentiate between the 
hemodynamic changes caused by the nature of the gas and the increased IAP. 
 
Ishizaki et al proposed that the maximum safe limit of intra-abdominal pressure 
that had minimal hemodynamic effects was 12 mmHg. Some changes caused by 
increased IAP include increased systemic vascular resistance and decreased 
cardiac output. Other manifestations include decreased intra-abdominal 
microcirculation, cardiac arrhythmias and increased catecholamine and 
vasopressin release.  
 
Since hemodynamically significant alterations were seen only when the PaCO₂ 
increased to more than 33 percent from baseline, incidentally it was thought that 
the insufflating gas had negligible systemic effects. This hypothesis was proved 
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by Kaminski et al in a canine model where similar hemodynamic changes were 
observed during both carbon dioxide and helium insufflations. However 
Saunders et al performed a study in a pig model where they compared carbon 
dioxide with nitrogen insufflations. They concluded that the hemodynamic 
changes were entirely due to carbon dioxide absorption and the resultant acid – 
base changes.  
 
CHANGES IN CARDIOVASCULAR SYSTEM: 
The filling pressure of the heart, pulmonary artery occlusion pressure and 
central venous pressure which are marginally reduced by induction of 
anaesthesia, increase when carbondioxide  insufflation starts. But the increased 
filling pressure is not associated with an increase in left ventricular end systolic 
or diastolic area. Lebovitz et al suggested that the systemic vascular resistance 
increase markedly during initial phases of insufflations and then restores to 
previous values partially, 10 – 15 minutes later. Rafferty et al suggested that the 
increase in mean arterial pressure represents an increase in afterload and is 
associated with an increase in left ventricular wall stress.  
 
The effect on cardiac output differs. Zuckerman et al has shown a 30 % 
reduction of CI, while others have shown no significant change. Dorsay et al 
found no difference in cardiac output  during  pneumoperitoneum. Anderson et 
al  and Myre et al, using invasive hemodynamic and transesophageal 
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measurements also showed that the cardiac index did not change during 
pneumoperitoneum. 
 
Both invasive and non invasive methods have been used to demonstrate the  
cardiovascular changes to pneumoperitoneum. Techniques like transthoracic 
bio-impedence, esophageal Doppler probe, transesophageal echocardiography 
and pulmonary artery catheter have been used and studied for this purpose. 
Majority of the methods report similar trends.  
 
Joris et al reported these hemodynamic changes to be phasic in nature. The 
initial fall in cardiac output and increase in systemic vascular resistance is later 
followed by an increase in the cardiac output and a fall in SVR ten minutes after 
insufflations of carbon dioxide.  
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CAUSES OF HEMODYNAMIC CHANGES: 
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dioxide becomes unlikely. The intra-peritoneal pressure effects and position 
changes are usually superimposed. They are insufficient or absent in patients 
with normal left ventricular function. 
 
Catecholamine and other humoral factors have been shown to increase after the 
onset of pneumoperitoneum. There is a marked elevation of plasma vasopressin 
concentration in patients undergoing laparoscopic surgeries. It may be triggered 
by neurogenic stimuli from peritoneal distension or chemical stimulation from 
carbondioxide. It can be speculated that these potential causal factors dissipate 
during sustained pneumoperitoneum.  
 
PATIENTS WITH CARDIAC DISEASE: 
Fumihiro et al studied the effects of laparoscopy in patients with already 
impaired cardiac function. They reported that the pattern of hemodynamic 
changes were similar to those of non cardiac patients. These patients showed a 
similar increase in CVP and PCWP and no significant change in heart rate, 
mean arterial pressure and cardiac output. But the increase in CVP and PCWP 
might not be well tolerated in these patients. Iwase et al reported a significant 
impairment of renal function and pulmonary edema in patients with cardiac 
disease. Uchikoshi et al commented that when pneumoperitoneum was used for 
long time in cardiac patients, it could precipitate cardiac failure.  
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PATIENT POSITIONING: 
During laparoscopic surgeries the patient is positioned to produce gravitational 
displacement of the abdominal viscera and for better visualisation of surgical 
site. The overall effect depends on the degree of tilt, whether the change in 
position is before or after pneumoperitoneum and suppression of reflexes by 
anaesthetic and cardiovascular drugs. Compensatory cardiovascular reflexes 
like the barorecepter reflex maintain the cardiovascular stability by responding 
to increased hydrostatic pressure with vasodilatation and bradycardia. Although 
these reflexes are attenuated during anaesthesia, effects  induced by these 
position changes remain insignificant.  
 
The reverse trendelenberg or head up position causes a decrease in venous 
return and a 11% decrease in cardiac output. The decrease in cardiac output 
depends on the degree of tilt. Steeper the tilt, more is the fall in cardiac output.  
The CVP and PCWP are also influenced by patient position. But it is usually 
favourable for respiration.  
 
The trendelenberg or head down position results in decreased total lung volume 
and compliance and favours development of atelectasis. This can be minimised 
by judicious administration of PEEP. These changes are more pronounced in 
obese, elderly debilitated patients and use of lithotomy position. It causes an 
increase in venous return and cardiac output and an increase in intracranial and 
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intraocular pressure. Brachial plexus injury, aspiration and endobronchial 
intubation are other problems of this position.  
 
Zuckerman et al showed that the position changes had no effect on the 
measured hemodynamic parameters. All hemodynamic parameters return to 
baseline over time because the effect of pneumperitoneum and position are 
short lived. 
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VENTILATORY EFFECTS OF 
PNEUMOPERITONEUM: 
The significant respiratory changes include limitation of diaphragmatic and 
abdominal wall movement, atelectasis, dead space ventilation, decreased lung 
volumes and increased shunt fraction and peak inspiratory pressure. Functional 
residual capacity ( FRC ) that is already decreased due to general anaesthesia, 
decreases further by 20 to 25 percent 5 minutes after pneumoperitoneum. The 
compliance decrease by 30 to 50 percent and the resistance increases by as 
much as 79 percent five minutes after pneumoperitoneum. These observations 
were suggested by Cereda M, et al. Some studies suggest that a 10 to 20 head 
up or head down position does not cause any significant alteration in shunt 
fraction or lung volumes.  
 
Flowers JL et al suggest that as early as 15 minutes after pneumoperitoneum 
these changes return to normal. These changes are well tolerated in healthy 
patients without any respiratory disease. In patients with baseline decrease in 
lung volumes and capacities, such as ASA III to IV, obese patients, there could 
be dramatic changes in pulmonary compliance, causing the lungs to shift to a 
flat non-compliant portion of the pressure – volume curve. The duration of 
pneumoperitoneum is insignificant unless complications such as bronchospasm 
or subcutaneous emphysema occur.  
 
31 
 
Using gasless laparoscopy, i.e., abdominal wall lift using fan retractor was 
suggested as an alternative in respiratory compromised patients. Though it 
significantly improves the effect on peak airway pressure and resistance, the 
elastance of respiratory system remains elevated. It is probably due to 
impairment of movement of the anterior abdominal wall and the diaphragm.  
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vena cava, which leads to an increased intra-cranial pressure. This rise in ICP is 
based on the Monroe – Kellie hypothesis. 
 
LATE CHEMICAL EFFECT : It is seen about 10 to 15 minutes after 
pneumoperitoneum. it is due to the reflex vasodilatation of the cerebral vessels 
causing an increase in cerebral blood flow. Hypoxia and hypercapnia caused 
due to ventilation perfusion mismatch in addition to the hypercapnia caused by 
the pneumoperitoneum are implicated for the  late increase in ICP.  
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Diminished  renal  blood flow triggers the renin – angiotensin – aldosterone 
axis. Renal protective measures such as dopamine infusions and warm carbon 
dioxide have been proved to be effective. The recently introduced gasless 
laparoscopy has been more favourable for renal function. High urine output has 
been demonstrated in this technique. 
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EFFECT ON INTRA-ABDOMINAL ORGANS: 
 
 
High IAP reduces the mesenteric blood flow, intestinal microcirculation and the 
mucosal pH. Stuttman et al and Burton et al have reported incidents of fatal 
intestinal ischaemia following laparoscopic surgeries. Blood flow to all 
abdominal organs is reduced by the high IAP, except the adrenal glands.  
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 COMPLICATIONS OF LAPAROSCOPIC SURGERIES:  
• Abdominal pain due to the irritant effect of carbon dioxide. 
• Shoulder pain due to the formation of carbonic acid. 
• CARBONDIOXIDE GAS EMBOLISM – It is rare but potentially fatal. Gas 
may enter circulation if a needle or trochar accidentally punctures a blood 
vessel. Early recognition and treatment improves outcome. If a gas embolism 
is suspected, the surgeon should be alerted, insufflations stopped, 100% 
oxygen used for ventilation, if possible the patient is put in left lateral tilt 
with head down position ( Durant’s position ). 
• PULMONARY ASPIRATION – Increased intra-abdominal pressure 
increases the competence of the gastro esophageal sphincter and thus the risk 
of regurgitation. Despite intubation with a cuffed tube, pulmonary aspiration 
is still possible. 
• PNEUMOTHORAX, SUBCUTANEOUS EMPHYSEMA AND 
PNEUMOMEDIASTINUM – It is due to the opening of the embryonic 
channels to the mediastinum, pleural cavity and pericardium. Subcutaneous 
emphysema is not uncommon after laparoscopic surgery for hernias, reflux 
esophagitis and obesity. Hypoxia and a rise in EtCO₂ are the usual 
presentations. 
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• THROMBOEMBOLISM – Due to the slowing of blood flow in the 
peripheral vascular system thrombosis can occur in the lower limbs. DVT 
may lead to pulmonary embolism. 
• CARDIOVASCULAR – Bradyarrhythmia is very common during 
laparoscopy. Arrhythmias, ventricular and supraventricular are also not 
infrequent. It can lead to hypotension and cardiovascular collapse. 
• POSTOPERATIVE NAUSEA AND VOMITING – PONV is very common 
following laparoscopic surgeries. It is a highly distressing complication. 
Ondansetron, a highly potent and selective 5-HT₃  antagonist has been 
proven to be very effective. 
• PROMOTION OF PORT SITE TUMOUR GROWTH – The mechanism by 
which this occurs is not clearly known. The theories suggested are – degree 
of tumour manipulation ; stage and aggressiveness of the tumour ; high IAP 
and gas turbulence producing a spray effect.  
Carboperitoneum has been implicated to cause port site metastasis by the 
inflammatory mediators released by the peritoneum. 
• ENDOBRONCHIAL INTUBATION – Increased intra abdominal pressure 
pushes the diaphragm upwards and causes cephalad movement of carina, 
leading to endobronchial intubation. It is identified intraoperatively by 
decrease in saturation and increase in plateau airway pressure.  
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STRESS RESPONSE AND LAPAROSCOPY: 
 
The onset of surgery is associated with a rapid increase in the anterior and 
posterior pituitary hormones – β endorphin, ACTH, growth hormone, prolactin, 
arginine and vasopressin together with release of adrenaline and noradrenaline. 
It is followed by increase in circulating cortisol, aldosterone and renin. With the 
increase in the catabolic hormones there is a decrease of anabolic hormones like 
insulin and testosterone. 
 
The unique feature of catabolic hormonal response is the absence of the normal 
negative feedback mechanisms. For example, the increased cortisol caused by 
ACTH, fails to inhibit further secretion of trophic hormones. 
 
Various studies have compared the stress markers of laparoscopy and 
laparotomy, mostly in cholecystectomy. The results showed no significant 
difference in the response, although few have shown a reduced response in 
favour of laparoscopy. 
 
Some studied the impact of anaesthesia on endocrine and immunological 
changes by investigating IL-6 and TNF-α levels. They confirmed that 
laparoscopic surgeries are associated with lesser immunoendocrine response 
and the type of anaesthesia does not influence it. 
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ANAESTHESIA FOR LAPAROSCOPY: 
PREOPERATIVE EVALUATION AND PREMEDICATION: 
Preoperative evaluation is essentially the same as for other surgical patients. 
Particular emphasis to be made on the cardiovascular and respiratory system. 
Patient’s cardiac status should be assessed and quantified prior to surgery. In 
COPD patients pulmonary function tests are advised. In both groups the positive 
effects of laparoscopy must be balanced against the intraoperative risks. 
 
DVT prophylaxis should be initiated prior to surgery. Due to the risk of 
regurgitation antacids, H₂ blockers and prokinetic agents are recommended.  
 
ANAESTHETIC TECHNIQUE :  
General anaesthesia with endotracheal intubation and controlled ventilation is 
the choice of anaesthesia. It allows adequate muscle relaxation, a quiet 
operative field and protection against aspiration. Minute volume has to be 
increased during carboperitoneum to maintain an EtCO₂ at about 35 mmHg.  
 
VOLATILE ANAESTHETICS : 
The choice of volatile anaesthetic should be based on the fact that it should 
counteract the increase in systemic vascular resistance caused by laparoscopy 
and not potentiate arrhythmias in the presence of hypercarbia. Since nowadays 
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most laparoscopic surgeries are performed as day care procedures, the recovery 
profile and PONV should also be considered. Anaesthetics that directly depress 
the myocardium should be avoided and agents with vasodilating properties such 
as isoflurane can be used.  
 
INTRAVENOUS ANAESTHETICS: 
Thiopentone, propofol, etomidate and midazolam can be used for the induction 
of anaesthesia. The considerations in choosing the agent are its myocardial 
depressant effect, action on peripheral vascular system, recovery profile and 
PONV. Benzodiazepines have modest hemodynamic effects and etomidate is a 
good choice in cardiac patients.  
 
TOTAL INTRAVENOUS ANAESTHESIA: 
Propofol with any short acting analgesic such as alfentanil, fentanyl and 
sufentanil are used for good recovery characteristics and surgical conditions. 
Because of a short context sensitive half-life, propofol gives good recovery 
characteristics.  
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MUSCLE RELAXANTS: 
The use of muscle relaxation and controlled ventilation has decreased the 
respiratory complications like high airway pressures and pneumothorax. 
Peterson et al revealed that almost one third of the deaths due to laparoscopic 
surgeries were due to use of general anaesthesia without intubation. The 
laryngeal mask airway could be used to improve safety in a patient breathing 
spontaneously.  
 
BENEFITS OF LAPAROSCOPY : 
• Faster recovery 
• Heightened feeling of well being 
• Reduced hospital stay and postoperative fasting 
• Lesser surgical trauma 
• Lesser incidence of postoperative pain 
• Lesser pulmonary dysfunction 
 
Various pharmacological agents have been used to prevent the hemodynamic 
response during laparoscopic surgeries. Nitroglycerine was used to correct the 
reduction in cardiac output associated with increased pulmonary arterial 
occlusion pressure and systemic vascular resistance. β blockers have been used 
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to blunt the response to noxious stimuli. α₂ agonists are known to inhibit the 
catecholamine and vasopressin rise associated with pneumoperitoneum. 
 
Considering all the above factors, this study was created with the aim of 
investigating whether i.v., magnesium sulphate, a well known inhibitor of 
catecholamines and vasopressin mediated vasoconstriction, can be used 
effectively to blunt the responses to pneumoperitoneum during laparoscopy. 
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AIM AND OBJECTIVE OF THE STUDY: 
PRIMARY OBJECTIVE: 
To assess the efficacy of magnesium sulphate on the attenuation of 
hemodynamic response to pneumoperitoneum during laparoscopic surgeries. 
SECONDARY OBJECTIVE: 
• To determine any adverse effects in the intra operative and postoperative 
period. 
• To determine the sedation in each group. 
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PHARMACOLOGY OF MAGNESIUM SULPHATE: 
INTRODUCTION: 
Magnesium is the second abundant intracellular cation. It is important for the 
function of several enzyme systems of the body. It plays a vital role in 
neurochemical transmission and membrane excitability. Its deficiency is 
associated with various structural and functional derangements. 
 
Magnesium sulphate is an inorganic salt containing magnesium, sulphur and 
oxygen with the formula MgSO₄. It is often encountered as the heptahydrate 
compound, commonly called as Epsom salt. Epsom salts are used as bath salts. 
Oral magnesium sulphate is commonly used as saline laxative or osmotic 
purgative. Magnesium sulphate is the main preparation of intravenous 
magnesium. 
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DRUG DESCRIPTION: 
 
Magnesium sulphate injection USP (50 %), for I.M and I.V use contains 500 mg 
of magnesium sulphate in each ml, which contain 4.06 mEq of magnesium and 
sulphate and water for injection. The pH (5.5 - 7.0) is adjusted with sulfuric acid 
and/or sodium hydroxide. The osmolarity is 4060 mOsm per litre. The solution 
contains no bacteriostatic agent or other preservatives. It is indicated for a single 
dose injection. Any unused portion has to be discarded. The molecular formula 
is MgSO4•7H2O and the molecular weight is 246.47. 
INDICATIONS: 
• Replacement therapy for hypomagnesemia. 
• As the first line anti-arrhythmic for torsades de pointes and quinidine 
induced arrhythmias. 
• As a bronchodilator after beta-agonists and anticholinergics have been tried. 
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• To treat eclampsia in pregnant women. 
• As a tocolytic to delay premature labour. 
• Antenatal intravenous magnesium sulphate has been shown to reduce 
cerebral palsy and gross motor dysfunction in preterm babies by 30%. 
• To prevent magnesium deficiency in patients receiving total parenteral 
nutrition. 
OTHER USES: 
• Stress attenuation during laryngoscopy and intubation. 
• Intra operative hemodynamic stability. 
• For management of box jellyfish poisoning due to its vasodilatory and 
skeletal muscle relaxation properties. 
• For management of paroxysmal atrial tachycardia, when all other measures 
have failed and there is no myocardial damage. The usual dose is 3 to 4 g. 
• For reduction of cerebral edema, a dose of 2.5 g can be given intravenously. 
DOSAGE AND ADMINISTRATION: 
• INTRAVENOUS: 1 to 4 g of a 10 to 20% solution can be given 
intravenously, but with caution. 
• INTRAVENOUS INFUSION: 4 g in 250 ml of 5% dextrose at a rate not 
more than 3 ml per minute. 
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• INTRAMUSCULAR: 1 to 5 g daily in divided doses, for severe 
hypomagnesemia in adults and older children. Serum magnesium levels 
should be monitored frequently and used as a guide to therapy. 
• USUAL DOSE RANGE: 1 to 40 g daily. 
• ELECTROLYTE REPLENISHMENT: 1 to 2 g of a 50% solution, four 
times a day, until the serum levels have normalised. 
• PAEDIATRIC DOSE: 20 to 40 mg per kg of a 20% solution, repeated if 
necessary. 
• FOR ECLAMPSIA: initially 1 to 2 g of a 25% or 50% solution is given I.M. 
subsequently 1 g is given every 30 minutes until relief is obtained.  
SIDE EFFECTS: 
• Flushing. 
• Sweating. 
• Sharply lowered blood pressure. 
• Hypothermia. 
• Stupor. 
• Depressed reflexes. 
• Flaccid paralysis. 
• Respiratory depression. 
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OVER DOSAGE: 
The therapeutic range for treating convulsions is 2.5 to 5 mEq/L. 
Hypermagnesemia will lead to the following features at various plasma 
concentrations: 
• 7.0-10.0 mEq/L - loss of patellar reflex 
• 10.0-13.0 mEq/L - respiratory depression 
• 15.0-25.0 mEq/L - altered atrioventricular conduction and (further) complete 
heart block 
• >25.0 mEq/L - cardiac arrest 
TREATMENT OF OVERDOSAGE: 
1. Intravenous calcium - 10 to 20 ml of a 5% solution of calcium chloride is 
given to counteract the effects of hypermagnesemia. 
2. Subcutaneous physostigmine 0.5 to 1 mg may be useful. 
3. Artificial respiration is often needed – assisted ventilation via endotracheal 
intubation or intermittent positive pressure ventilation. 
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WARNINGS: 
• Since the drug is almost exclusively excreted in the kidneys, caution is 
advised in case of renal dysfunction. 
• In case of renal insufficiency, no more than 20 grams should be given within 
a 48 hour period. 
• The main concern of parenteral magnesium is hypermagnesemia. It 
manifests as flushing, sweating, hypotension, stupor and cardiovascular 
collapse. Respiratory depression is the immediate danger to life. 
• Any calcium preparation, such as calcium gluconate must be ready at any 
time, as an intravenous antidote. 
 
PRECAUTIONS: 
1. When used in conjuction with other respiratory depressants such as 
narcotics, barbiturates and benzodiazepines, their dose should be reduced to 
prevent the additive effect. 
2. Its teratogenic effects in the fetus have yet to be studied. Hence it is to be 
given to a pregnant patient only if absolutely indicated. 
3. Monitoring of patellar reflex and respiratory rate. The drug causes a 
depression in patellar reflex at a serum level of 7 mEq/L and respiratory 
depression at 10 mEq/L. 
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4. The 50% solution should be diluted to a concentration of 20% or less before 
parenteral administration. Commonly used solutions are 5% dextrose and 
0.9% sodium chloride.  
CONTRAINDICATIONS: 
1. Complete heart block. 
2. Renal dysfunction. 
3. Hypermagnesemia. 
CLINICAL PHARMACOLOGY: 
Magnesium prevents convulsions by decreasing the level of acetylcholine 
released from the neuromuscular junction.  
Normal plasma magnesium concentration is 1.5 to 2.5 mEq/L. 
As the level rises to 4 mEq/L the deep tendon reflexes decrease and are lost at a 
level of 10 mEq/L. Cardiac and respiratory depression may also occur at this 
level. A plasma magnesium of 12 mEq/L may be fatal. 
Magnesium acts peripherally to produce vasodilatation. At low dose it causes 
flushing and sweating and at higher doses it could lead to hypotension. Calcium 
acts as an antagonist to both the central and peripheral actions of magnesium. 
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PHARMACOKINETICS: 
Following intravenous infusion, the onset is immediate and the duration is 30 
minutes. Following intramuscular injection the onset is delayed by one hour, 
and the duration of action is 3 to 4 hours. 
The drug is solely excreted by the kidneys and the rate of excretion is directly 
proportional to the glomerular filtration rate. 
DRUG INTERACTIONS: 
1. CNS depressants – additive effect with barbiturates, narcotics and 
benzodiazepines. 
2. Neuromuscular blockers – excessive neuromuscular blockade and 
prolongation of action can occur. 
3. Cardiac glycosides – magnesium should be administered with extreme 
caution in digitalised patients because serious conduction abnormalities can 
occur. 
AVAILABILITY: 
• 2 ml single dose vial. 
• 10 ml single dose vial. 
• 50 ml single dose vial. 
It could be stored at a room temperature of 15 to 30 degrees. Since it contains 
no preservatives, the unused portion has to be discarded.  
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REVIEW OF LITERATURE 
Several studies have been conducted to study the hemodynamic changes and the 
catecholamine response during laparoscopic surgeries. The efficacy of 
magnesium sulphate in attenuation of the neuroendocrine response has also 
been studied. 
1. British Journal of Anaesthesia 103 (4): 484–9 (2009)  
D. Jee, D. Lee, S. Yun and C. Lee. 
“Magnesium sulphate attenuates arterial pressure increase during 
laparoscopic cholecystectomy.” 
In this study, 35 ASA I patients undergoing elective cholecystectomy were 
chosen. All patients were premedicated with Inj. Glycopyrrolate 0.2 mg one 
hour before surgery. Induction of anaesthesia and intubation was done after 
midazolam 0.05 mg/kg, sodium thiopental 3 – 5 mg/kg and vecuronium 0.1 
mg/kg. Before pneumoperitoneum the control group received i.v., normal saline 
0.5 ml/kg and the study group received i.v., magnesium sulphate in the dose of 
50 mg/kg, diluted in normal saline to 0.5 ml/kg and made as a 10% solution. 
The infusion was given slowly over 2 -3 minutes. 
No opioids or any analgesics was given in both groups throughout the surgery. 
In both groups the anaesthesia was maintained with N₂O and O₂ in the ratio 1:1 
at 4 litres per minute and a end tidal sevoflurane concentration of 1.5 – 2.5 %. 
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Standard monitoring devices were used and during pneumoperitoneum, the intra 
abdominal pressure was maintained at 14 mm Hg. 
Arterial pressures, heart rate, serum magnesium, plasma renin activity and 
catecholamine, cortisol and vasopressin levels were measured in both groups. 
Results: Systolic and diastolic blood pressures were higher in the control group 
than the study group at 10, 20, 30 minutes post pneumoperitoneum. The 
vasopressin and catecholamine levels were also significantly higher in the 
control group than the magnesium group. There was no significant difference in 
the rennin and cortisol levels between the two groups. 
Conclusion: Magnesium sulphate attenuates the arterial pressure increase and 
the catecholamine response to pneumoperitoneum during laparoscopic 
surgeries.  
 
2. Indian Journal of Anaesthesia 2008; 52 (6):800-804. 
Dilip Kothari, Amrita Mehrotra, Bhanu Choudhary, Alok Mehra. 
“Effect of Intravenous Magnesium Sulfate and Fentanyl Citrate on 
Circulatory Changes During Anaesthesia and Surgery: A Clinical Study.” 
In this study the circulatory effects of fentanyl citrate and magnesium sulphate 
were compared during general anaesthesia and surgery. Sixty ASA I and II 
patients were chosen with 30 in each group. The magnesium group was given 
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intravenous magnesium sulphate 20mg/kg 5 minutes before induction, 10 mg/kg 
5 minutes before skin incision and 10 mg/kg every 30  minutes thereafter. The 
fentanyl group was given intravenous fentanyl citrate 1.25 mcg/kg, 0.5 mcg/kg 
and 0.5 mcg/kg at similar intervals. General anaesthesia was standardised in 
both groups with controlled ventilation, O₂ , N₂O and 0.2% halothane and 
relaxants in both groups. The baseline pulse rate, systolic blood pressure, 
diastolic blood pressure and mean arterial pressure was monitored and was 
subsequently recorded at regular intervals. There was a rise in all the 
hemodynamic variables immediately after intubation in both groups and 
returned to near baseline values thereafter. There was no statistically significant 
difference between the variables in both groups. Therefore this study suggests 
that magnesium sulphate could be used as a safe and cheap alternative to 
fentanyl citrate during surgeries under general anaesthesia.  
 
3. Journal of Research in Medical Sciences 2005; 10(2): 82-86. 
K. Montazeri MD, M. Fallah MD. 
 A Dose – Response Study of Magnesium Sulfate in Suppressing 
Cardiovascular Responses to Laryngoscopy & Endotracheal Intubation. 
This study was done with the aim of estimating the optimal dose of magnesium 
sulphate that attenuates the cardiovascular responses to laryngoscopy and 
tracheal intubation. 120 ASA I patients between age group 15 and 50 years, 
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undergoing elective surgeries were chosen and were divided into six groups of 
twenty each. Each group received 10, 20, 30, 40 and 50 mg/kg of intravenous 
magnesium sulphate and the sixth group received 1.5 mg/kg of lidocaine. In all 
the groups the drug was given 1 minute before induction of anaesthesia. 
Induction was standardised with fentanyl 1 mcg/kg, atracurium 0.5 mg/kg and 
sodium thiopental 5  mg/kg in all groups.  
Pulse rate and blood pressure was measured 5 minutes before giving any drug, 
just before laryngoscopy and 1, 3, and 5 minutes after intubation. Train of four 
was measured 45 minutes after induction of anaesthesia.  
Results: There was no significant difference in the monitored parameters 
between the magnesium groups, but there was a significant difference between 
the magnesium and lidocaine groups. 
Conclusion: The cardiovascular response suppression effect was more effective 
with magnesium sulphate than with lidocaine. 
 
4. ANAESTHESIA ANALGESIA 1989;68:772-6. 
Intravenous Magnesium Sulfate Inhibits Catecholamine Release Associated 
with Tracheal Intubation. 
Michael F. M. James, FFARCS, R. Eryk Beer, FFA(SA), and Jan D. Esser, 
MMED. 
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The effect of 60 mg/kg of magnesium sulphate on cardiovascular response and 
catecholamine release associated with tracheal intubation was studied. 15 
patients in each group were chosen. Group A patients received 60 mg/kg of 
50% magnesium sulphate intravenously over 1 minute, while group B received 
normal saline. After intubation, the heart rate was unchanged and the rise in 
systolic blood pressure was insignificant in group A. Epinephrine levels were 
unchanged from baseline in the control group. Thus, this study concludes that 
magnesium sulphate attenuates the arterial pressure increase and catecholamine 
response to laryngoscopy and intubation.  
 
5.J Urol. 1996 Apr;155(4):1368-71.  
Catecholamine release caused by carbon dioxide insufflation during 
laparoscopic surgery. 
Mikami O, Kawakita S, Fujise K, Shingu K, Takahashi H, Matsuda T. 
This study evaluated the epinephrine and norepinephrine levels in 29 patients 
who underwent laparoscopic surgeries. The levels were found to be 
significantly higher five minutes after CO₂ insufflations than during Veress 
needle insertion or just before pneumoperitoneum. This study concluded that 
catecholamine release was associated with pneumoperitoneum during 
laparoscopic surgeries.  
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6.Br J Anaesth. 1997 Mar;78(3):264-6. 
Role of vasopressin in the haemodynamic response to laparoscopic 
cholecystectomy. 
Walder AD, Aitkenhead AR. 
In this study 10 patients undergoing laparoscopic cholecystectomy were studied, 
with 5 patients undergoing elective limb surgeries under general anaesthesia as 
control. The parameters monitored were arterial pressure, heart rate, right atrial 
pressure, cardiac index, adrenaline, noradrenaline and arginine vasopressin 
concentrations. Arginine vasopressin levels were found to be elevated in the 
study group after insufflation of pneumoperitoneum and it caused significant 
hemodynamic changes.  
 
7.British Journal Of Anaesthesia 
Volume 104, (Number 4): 465-7; October 2009. 
Magnesium: an emerging drug in anaesthesia. 
The role of magnesium has been advanced and exemplified in the past century. 
Extensive obstetric research indicated that it is the best drug for the treatment of 
eclamptic seizures, although the mechanism is unknown. Apart from it, 
numerous studies have been conducted to establish its cardiovascular effects. 
These studies show that it is an effective arteriolar dilator, without causing 
venodilation, thus improving cardiac output and filling. When the 
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catecholamine levels are high, it is shown to be an excellent alpha adrenergic 
antagonist while preserving its beta agonistic effects. It is used for the treatment 
of torsades de pointes and also protects against catecholamine induced 
arrhythmias. It is a very safe drug with a therapeutic ratio of 10:1. Plasma 
concentrations of upto 6 mmol/L are hemodynamically safe and a concentration 
of 9 mmol/L causes only moderate hypotension.  
 
8.Br. J. Anaesth. (1989) 62 (6): 616-623.  
 Use of magnesium sulphate in the anaesthetic management of 
phaeochromocytoma: a review of 17 anaesthetics 
M. F. M. James, M.B., CH.B., F.F.A.R.C.S. 
Seventeen patients with pheochromocytoma, undergoing elective surgery under 
general anaesthesia were included in this study. In these patients intravenous 
magnesium sulphate was used as the principal anti adrenergic agent. It was 
found to be effective in controlling the cardiovascular changes to induction and 
anaesthesia in 15 of them, and 4 of them required additional nitroprusside 
intraoperatively. The catecholamine levels were studied and magnesium was 
found to significantly reduce the catecholamine levels too. 
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9.Br. J. Anaesth. (2002) 89 (4): 594-598.  
Evaluation of effects of magnesium sulphate in reducing intraoperative 
anaesthetic requirements 
L. Telci, F. Esen, D. Akcora, T. Erden, A. T. Canbolat and K. Akpir. 
In this study 81 patients undergoing elective spinal surgeries were included in 
two parallel groups. One group received 50 mg/kg of intravenous magnesium 
sulphate preoperatively and an infusion of 10 mg/kg/hr intraoperatively. The 
other group received equal volumes of normal saline. Anaesthesia was 
maintained with propofol and remifentanil. It was found that the  requirement of 
propofol, remifentanil and vecuronium was significantly lesser in the 
magnesium group compared to the control group.  
 
10.Br. J. Anaesth. (2005) 94 (4): 438-441. 
 Effects of magnesium sulphate and clonidine on propofol consumption, 
haemodynamics and postoperative recovery 
A.Altan, N. Turgut, F. Yildiz, A. Turkmen and H. Ustun 
Sixty ASA II patients undergoing elective spine surgeries were divided into 
three groups. Group I received 30 mg/kg of intravenous magnesium sulphate 
before induction and a infusion of 10 mg/kg/hr intraoperatively. Group II 
received 3 mcg/kg of clonidine before induction and an infusion of 2 mcg/kg/hr. 
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The third group received normal saline in equal volumes. Anaesthesia was 
maintained with propofol, fentanyl and cisatracurium.  
Induction of anaesthesia was rapid in the magnesium group and the 
requirements of propofol and fentanyl were lower in both magnesium and 
clonidine group.  
Conclusion: Clonidine causes hypotension and bradycardia. Magnesium, 
inspite of causing a delayed recovery can be used as an adjuvant 
intraoperatively. 
 
11.Br. J. Anaesth. (1991) 66 (2): 216-223. 
 Attenuation of the pressor response to tracheal intubation in hypertensive 
proteinuric pregnant patients by lignocaine, alfentanil and magnesium 
sulphate  
R. W. Allen, M.B., CH.B., F.F.A.R.C.S.I., M. F. M. James, M.B., CH.B., 
F.C.ANAES. and P. C. Uys, M.B., CH.B., F.F.A.(S.A.). 
The attenuation of the pressor response to intubation was studied in pregnant 
patients with gestational hypertension. A comparison was done between 
lignocaine 1.5 mg/kg, magnesium sulphate 40 mg/kg and alfentanil 10 mcg/kg 
in 69 pregnant patients. The systolic arterial pressure was found to be higher in 
the lignocaine group, 5 minutes after intubation and there was no increase in the 
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arterial pressure in the other two groups. Of the three drugs, alfentanil caused 
the least increase in heart rate, but with some amount of fetal depression. 
 
12.Anesthesiology: November 2002 - Volume 97 - Issue 5 - pp 
1137-1141. 
Choi, Jae Chan; Yoon, Kyung Bong; Um, Dae Ja; Kim, Chan; Kim, Jin 
Soo; Lee, Sang Gyu. 
This study was done with the aim of evaluating whether intravenous magnesium 
sulphate decreases the requirement of propofol infusion during maintainance of 
anaesthesia. 54 patients undergoing elective abdominal hysterectomy were 
chosen and divided into two groups. The control group received normal saline, 
while the study group received magnesium sulphate 50 mg/kg bolus and a 
maintainance dose of 8 mg/kg/hr. The infusion rate of propofol was adjusted 
according to the heart rate and mean arterial pressure.  
Conclusion: The propofol infusion rate was significantly lower in the 
magnesium group than the control group. This proves that magnesium sulphate 
has an effect on anaesthesia and analgesia.  
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13.Can J Physiol Pharmacol. 1987 Apr;65(4):729-45. 
Mg2+-Ca2+ interaction in contractility of vascular smooth muscle. 
Altura BM, Altura BT, Carella A, Gebrewold A, Murakawa T, Nishio A. 
Studies on both arteriolar and venular smooth muscles of all types of blood 
vessels was done. It has been shown that only magnesium has the ability to 
inhibit the basal, myogenic and hormonal tone in vascular smooth muscles of all 
types of blood vessels. Due to the heterogenecity of the Ca2+ binding sites and 
the receptors ( ligand- ,voltage- and leak- operated ), the organic calcium 
channel blockers have a selective action on specific receptors. Magnesium is 
found to have a special calcium antagonistic action, though it is three to five 
times less potent than the calcium channel blockers. 
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METHODOLOGY 
SOURCES OF DATA: 
The data was collected from 60 ASA I patients scheduled to undergo 
laparoscopic surgeries ( laparoscopic appendicectomy and cholecystectomy ) 
under general anaesthesia, aged between 18 and 50 years. The study was 
conducted in Government Rajaji hospital, Madurai Medical College.  
INCLUSION CRITERIA: 
• Patients undergoing elective laparoscopic surgeries 
• Age 18 to 60 years 
• Both sex 
• ASA I patients 
EXCLUSION CRITERIA: 
• Age <18 years , and >60 years 
• ASA II or more patients 
• Hypermagnesemia 
• Allergy to magnesium sulphate 
• Heart block 
• Diabetes mellitus 
• Systemic hypertension 
• Cardiovascular or kidney disease 
• Endocrine or metabolic disease 
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• Severe haemorrhage during the surgery 
• Conversion to open procedure 
• Need for any anti-hypertensive during the surgery 
• Duration of surgery less than 30 minutes 
METHODS:  
The study is a randomised, prospective, double blinded control study. After 
obtaining approval from the institutional review board and informed consent 
sixty ASA I patients undergoing elective laparoscopic surgeries were enrolled in 
the study. 
Pre – anaesthetic evaluation: 
1. History of diabetes, hypertension or any cardiovascular disease. 
2. History of any respiratory tract infection, wheezing or chronic chest 
infections. 
3. History of seizures or neuromuscular disease/weakness. 
4. History of any drug intake or allergic reactions to any drugs. 
5. History of previous surgeries and any significant events. 
6. Relevant investigations – haemoglobin, blood sugar, blood urea, serum 
creatinine, serum electrolytes, urine analysis. 
7. Informed consent from patients. 
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All patients were premedicated with Diazepam 10 mg orally the night before 
surgery. Glycopyrrolate 0.2 mg i.m., and ranitidine hydrochloride 50 mg i.v., 
was given 1 hour before surgery. After shifting the patient into the operating 
room, pulseoximeter, NIBP and ECG leads were connected. Intravenous line 
was secured. A nasogastric tube was inserted and suction was applied to empty 
the stomach before intubation.  
 
Preoxygenation was done with 100% oxygen for 3 minutes. All patients were 
induced with fentanyl citrate 2 mcg/kg, thiopentone sodium 3-5 mg/kg and 
suxamethonium 1.5 mg/kg for muscle relaxation. Proper sized cuffed oral 
endotracheal tube was inserted, cuff was inflated and connected to closed circuit 
for controlled ventilation. Immediately before pneumoperitoneum the patients 
were randomly allocated into two groups using sealed envelopes chosen by the 
patients preoperatively. The control group received normal saline 0.5 ml/kg i.v. 
The study group received  0.5 ml/kg of 10% magnesium sulphate ( 50 mg/kg ) 
i.v., over 2 – 3 minutes. The drug was given 1 minute before 
pneumoperitoneum in both groups.  
 
Anaesthesia was maintained with 66% nitrous oxide and 33% oxygen and 1 – 2 
% sevoflurane. Atracurium 0.5 mg/kg bolus was given and 0.1 mg/kg was used 
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for maintainance of muscle relaxation. Fentanyl citrate 0.5 mcg/kg was given 
every 30 minutes thereafter. Ventilation was adjusted to maintain a end tidal 
CO₂ of 35 – 40 mm Hg. Carbondioxide pneumoperitoneum was established and 
the intra abdominal pressure was maintained between 13 – 15 mm Hg. Ringer 
lactate solution was administered in according to the fasting period, 
maintainance volume and blood losses. Neuromuscular monitoring was done 
using train of four to look for any prolongation of the muscle relaxant action.  
 
The hemodynamic parameters were measured by an anaesthetist who was 
unaware of the study, to make it double blinded. The systolic and diastolic 
blood pressures and the pulse rate was measured at the following intervals : 
Baseline / preoperative 
• 0 minute/ before pneumoperitoneum 
• 5 minutes after pneumoperitoneum 
• 10 minutes after pneumoperitoneum 
• 15 minutes after pneumoperitoneum 
• 20 minutes after pneumoperitoneum 
• 30 minutes after pneumoperitoneum 
• 45 minutes after pneumoperitoneum 
• 60 minutes after pneumoperitoneum 
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At the end of surgery glycopyrrolate 0.01 mg/kg and neostigmine 0.05 mg/kg 
was used for reversal of muscle relaxation. After thorough suctioning and 
nasogastric tube aspiration the tracheal tube was removed.  
 
Patients in whom the pneumoperitoneum was terminated within 30 minutes and 
those who needed other i.v., antihypertensives were excluded from the study. 
Post operative sedation was monitored for 6 hours using the Ramsay’s sedation 
score. Patients were monitored for other signs of hypermagnesemia and serum 
magnesium levels were measured in the  post operative period in the 
magnesium group.  
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RAMSAY’S SEDATION SCORE: 
1. anxious and agitated or restless or both 
2. cooperative and oriented 
3. responds to oral commands only 
4. brisk response 
5. sluggish response 
6. no response 
LEVEL 1 – 3: patient awake 
LEVEL 4 – 6: patient asleep, responds to light glabellar tap or loud auditory 
stimulus 
SIGNS OF HYPERMAGNESEMIA: 
• weakness/ flaccid paralysis/ depressed reflexes 
• nausea and vomiting 
• impaired breathing 
• decreased respiration 
• arrhythmias and asystole 
• decreased or absent tendon reflexes 
• hypotension, flushing 
• bradycardia 
• hypocalcemia and paralytic ileus 
  
70 
 
STATISTICAL TOOLS: 
The information collected regarding all the selected cases were recorded 
in a Master Chart. Data analysis was done with the help of computer using 
Epidemiological Information Package (EPI 2010) developed by Centre for 
Disease Control, Atlanta.  
 Using this software range, frequencies, percentages, means, standard 
deviations, chi square and  'p'  values were calculated. Kruskul Wallis chi-square  
test was used to test the significance of difference between quantitative 
variables and Yate’s chi square test for qualitative variables. A 'p' value less 
than 0.05 is taken to denote significant relationship. 
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RESULTS: 
Table 1: 
Age distribution 
 
Age group 
Magnesium 
group 
Control 
group 
No % No % 
Upto 20 years 7 23.3 7 23.3 
21-30 years 11 36.7 11 36.7 
31-40 years 5 16.7 5 16.7 
41-50 years 5 16.7 4 13.3 
> 50 years 2 6.7 3 10.0 
Total 30 100 30 100 
Range 18 - 54 years 18 - 56 years 
Mean 30.9 years 31.1 years 
SD 11.3 years 11.7 years 
‘p’ 0.9646  
Not significant 
 
Table 1 shows that there was no significant difference in the age distribution 
between both groups. 
   
Figure 1a 
Age Distribution mean  
 
 
 
 
 
Figure 1b  
Age distribution no of cases 
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Table2: 
Sex distribution 
 
 
Sex 
 
 
Magnesium 
group 
 
Control 
group 
 
No 
 
% No % 
 
Male 
 
14 46.7 17 56.7 
 
Female 
 
16 53.3 13 43.3 
 
Total 
 
30 100 30 100 
 
‘p’ 
 
0.6054 
Not significant 
 
Table 2 shows that there was no significant difference in the sex distribution 
between both groups.  
 
Figure 2a 
Sex distribution 
 
 
 
 
 
 
Figure 2b 
Sex Distribution in percentage 
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Table 3: 
Duration of surgery 
Duration of surgery ( in minutes) 
   Magnesium group Control group 
Range 62 - 119 62 - 120 
Mean 85.2 85.4 
SD 16.1 15.7 
‘p’ 
0.9764 
Not significant 
 
Table 3 shows that there is no significant difference in the duration of surgery 
between both groups 
   
 Figure 3 
 Mean duration of surgery 
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Table 4:  
Changes in systolic B.P 
 
 
 
SBP at 
Systolic BP in  
 
‘p’ 
 
 
Significance 
Magnesium 
Group 
Control group 
Mean SD Mean SD 
Baseline 118.0 8.9 116.7 7.7 0.6451 
Not 
significant 
0 minute 120.8 13.1 120.3 8.9 0.8704 
Not 
significant 
5 minutes 122.7 10.9 122.5 7.0 0.9408 
Not 
significant 
10 minutes 123.0 12.4 129.5 10.6 0.0305 Significant 
15 minutes 125.0 11.7 132.5 14.1 0.0263 Significant 
20 minutes 126.6 10.5 136.7 11.2 0.0001 Significant 
30 minutes 128.8 12.1 136.4 12.0 0.0338 Significant 
45 minutes 125.4 13.2 136.4 14.4 0.0025 Significant 
60 minutes 127.4 10.1 136.3 11.5 0.0015 Significant 
 
Table 4 shows that there is a significant difference in the systolic blood 
pressure between the magnesium group and the control group at 10, 15, 20, 30 
45 and 60 minutes post pneumoperitoneum. 
  
Figure 4a 
Mean systolic BP 
 
 
 
 
 
Figure 4b 
Mean systolic BP 
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Table 5:  
Intra operative Changes in Systolic B.P from baseline 
 
 
SBP at 
Systolic BP in 
 
 
‘p’ 
 
 
Significance
Magnesium 
Group 
Control 
group 
Mean SD Mean SD 
Baseline 118.0 8.9 116.7 7.7 0.6451 
Not 
significant 
Maximum reached 
during Intra 
operative period 
134.1 8.6 143.1 9.9 0.0009 Significant 
Changes during 
Intra operative 
period 
16.1 8.9 26.4 10.5 0.0003 Significant 
Percentage of 
Changes during 
Intra operative 
period 
14.0 8.3 22.9 9.6 0.0007 Significant 
 
Table 5 shows that the changes in the systolic BP in the magnesium group was 
14 % from the baseline and in the control group it was upto 22.9% from the 
baseline which is statistically significant. 
   
 
Figure 5  
Intraoperative changes in systolic BP from baseline 
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Table 6:  
Changes in diastolic blood pressure 
 
 
DBP at 
Diastolic BP in 
 
 
‘p’ 
 
 
SD 
Magnesium 
Group 
Control group 
Mean SD Mean SD 
Baseline 77.2 6.9 76.4 6.2 0.8779 
Not 
significant 
0 minute 76.4 10.9 79.6 4.8 0.0026 Significant 
5 minutes 79.7 8.5 81.2 6.9 0.0465 Significant 
10 minutes 81.3 6.8 85.1 5.2 0.0304 Significant 
15 minutes 81.4 7.2 84.8 7.4 0.0412 Significant 
20 minutes 80.6 9.7 85.7 8.5 0.0065 Significant 
30 minutes 82.5 9.1 86.0 9.0 0.0274 Significant 
45 minutes 79.7 7.6 85.3 8.3 0.016 Significant 
60 minutes 78.4 6.9 84.1 8.4 0.0087 Significant 
 
Table 6 shows that there was a significant difference in the diastolic BP 
between the magnesium group and the control group from the beginning of 
pneumoperitoneum. 
  
Figure 6a 
Changes in diastolic BP 
 
 
 
 
 
 
 
 
 
Figure 6b 
Changes in diastolic BP 
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Table 7:   
Intra operative Changes in Diastolic B.P from baseline 
` 
 
 
DBP at 
Diastolic BP in 
 
 
‘p’ 
 
 
Significance 
Magnesium 
Group 
Control 
group 
Mean SD Mean SD 
Baseline 77.2 6.9 76.4 6.2 0.1779 Not significant
Maximum reached 
during Intra operative 
period 
89.5 7.5 90.6 6.1 0.1649 Not significant
Changes during Intra 
operative period 
12.3 6.1 14.2 5.5 0.2366 Not significant
Percentage of Changes 
during Intra operative 
period 
16.3 8.6 19.0 8.0 0.3702 Not significant
 
Table 7 shows that the change in diastolic BP in the magnesium group was 16% 
from baseline and in the control group was 19% from baseline. 
 
 
  
 
Figure 7  
Intraoperative changes in diastolic BP from baseline 
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Table 8:  
Changes in heart rate 
 
 
Heart rate at 
Heart rate at  
 
‘p’ 
 
 
SD 
Mag. Group Control group 
Mean SD Mean SD 
Baseline 86.7 14.2 83.1 9.5 0.3338 Not significant
0 minute 88.0 14.0 85.3 7.3 0.3654 Not significant
5 minutes 86.3 11.0 89.1 7.2 0.2101 Not significant
10 minutes 86.6 11.5 94 6.3 0.0217 Significant 
15 minutes 88.1 12.7 94.5 7.8 0.0487 Significant 
20 minutes 88.0 11.7 93.7 11.5 0.0415 Significant 
30 minutes 87.0 11.0 94 11.5 0.0204 Significant 
45 minutes 88.7 10.6 95.8 10.5 0.0461 Significant 
60 minutes 88.0 11.1 96 8.6 0.0163 Significant 
 
Table 8 shows that there was a significant difference in the heart rate between 
both groups from 10 minutes after pneumoperitoneum 
 
  
Figure 8a 
Changes in heart rate 
 
 
 
 
 
 
 
Figure 8b 
Changes in heart rate 
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Table 9:   
Intra operative Changes in Heart Rate from baseline 
 
 
 
Heart Rate at 
Heart Rate in  
 
‘p’ 
 
 
Significance 
Magnesium 
Group 
Control 
group 
Mean SD Mean SD 
Baseline 86.7 14.2 83.1 9.3 0.3338 Not significant
Maximum reached 
during Intra operative 
period 
95.2 12.9 100.5 8.3 0.239 Not significant
Changes during Intra 
operative period 
8.5 9.1 17.4 7.2 0.0001 Significant 
Percentage of Changes 
during Intra operative 
period 
10.8 12.5 21.8 10.4 0.0001 Significant 
 
Table 9 shows that the maximum change in heart rate in the magnesium group 
was 10.8% from the baseline and in the control group was 21.8% from the 
baseline which is statistically significant. 
  
 
Figure 9 
Intraoperative changes in heart rate from baseline 
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Table 10 
Intraoperative fentanyl requirements 
 
FENTANYL REQUIREMENT in mcg 
 
 
 
Magnesium group 
 
Control group 
 
Range 
 
80 - 160 80 - 140 
 
Mean 
 
109.7 116.7 
 
S.D 
 
18.8 14.7 
 
P 
 
0.1461 – Not significant 
 
Table 10 shows that there is no significant difference in the inraoperative 
fentanyl requirement between both groups 
 
  
 
Figure 10 
Intraoperative fentanyl requirements 
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Table 11:  
Sedation score 
 
Sedation score 
 
 
Magnesium group
 
Control group 
No % No % 
 
1 
 
13 43.3 13 43.3 
 
2 
 
17 56.7 17 56.7 
 
Range 
 
1 - 6 1 - 6 
 
‘p’ 
 
1.0 
Not significant 
 
Table 11 shows that there is no significant difference in the postoperative 
sedation between both groups 
  
 
Figure 11  
Sedation score 
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DISCUSSION 
Pneumoperitoneum during carbondioxide insufflation is known to cause 
significant hemodynamic changes. It is due to rapid and immediate increase of 
plasma catecholamines, probably due to stretching of the peritoneum, increased 
intraperitoneal pressure and the stimulation of the peritoneum by carbondioxide. 
Many studies have been done to prove the catecholamine response as the cause 
for these hemodynamic changes.  Various pharmacological agents and various 
techniques have been used to counteract these detrimental effects. 
 
Several studies have been done with focus on the hemodynamic changes during 
laparoscopic surgeries. This randomised double blinded prospective study was 
conducted in 60 patients to evaluate the effects of magnesium sulphate in 
attenuation of the hemodynamic changes.  
 
Though magnesium has been used for a number of  conditions including 
eclampsia, asthma, seizures, arrhythmias and preterm labour its use in 
laparoscopic surgeries have not been studied. It has been used effectively for 
stress attenuation during laryngoscopy and intubation, for reducing the 
intraoperative anaesthetic requirements and has also been used for suppression 
of the cardiovascular responses during pheochromocytoma surgery.  
Magnesium has been shown to inhibit the release of catecholamines both in 
vivo and in vitro and also act as a vasodilator by reducing the tone of the 
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vascular smooth muscles. So this study was conducted with the aim of using 
this property of magnesium in the very commonly done laparoscopic surgeries, 
to prove that it could be a cheap and effective alternative to maintain stable 
intraoperative hemodynamics. 
 
Various doses of magnesium sulphate have been used for suppression of 
cardiovascular response to intubation. A dose of 10, 20, 30, 40, 50 and 60 
mg/kg have all been used successfully during laryngoscopy and intubation. A 
bolus dose of 50 mg/kg of intravenous magnesium sulphate has been shown to 
effectively blunt the catecholamine response in various standard journals and 
publications. It is proven to produce a plasma magnesium concentration of 2 – 4 
mmol/L, which is required to produce these effects.   
 
There was no significant difference between the two groups in terms of age 
distribution, sex distribution and the duration of surgery. The mean age was 
30.86 ± 11.32 years in the magnesium group and 31.06 ± 11.72 years in the 
control group. The ratio of number of male patients to the number of female 
patients was also comparable between both groups. The average duration of 
surgery was also not significant between both groups.  
There was a significant difference between the systolic blood pressure between 
the magnesium group and the control group. But this difference occurred only 
10 minutes post pneumoperitoneum. The systolic blood pressure was ranged 
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between 118.03 ± 8.85 to 127.37 ± 10.15 in the magnesium group and 116.73 ± 
7.67 to 136.3 ± 11.53 in the control group.  
 
There was also a significant difference between the diastolic blood pressures in 
both groups. The range of diastolic blood pressure was between 77.23 ± 6.88 
and 78.37 ± 6.92 in the magnesium group and 76.37 ± 6.22 and 84.1 ± 8.39 in 
the control group. 
 
There was a significant difference in heart rate between both groups from 10 
minutes after pneumoperitoneum. The range of heart rate was between 86.7 to 
88 per minute in the magnesium group and 83.1 to 96 per minute in the control 
group. 
 
Throughout the intraoperative period the TOF response was monitored using a 
neuromuscular monitor and no prolongation of the blockade was found in the 
magnesium group. There was also no significant difference in the postoperative 
sedation between both groups. All patients were awake, alert and conscious at 
the end of surgery. 
No significant adverse effects were observed in the study group throughout the 
intraoperative and postoperative period. At the end of surgery serum 
magnesium levels were done in the magnesium group. The levels were found to 
be normal within 2±0.2 mEq/L.  
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There were some limitations in the study. First, if plasma epinephrine, 
norepinephrine and vasopressin levels were monitored during the study it would 
have been a better evidence for the catecholamine and vasopressin suppression 
effect of magnesium sulphate. Second, the use of BIS monitor would have 
ensured that both groups had similar depth of anaesthesia.  
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SUMMARY 
60 patients coming to Government Rajaji Hospital for elective laparoscopic 
surgeries were included in this study. The patients were randomly divided into 
two groups to receive intravenous magnesium sulphate 50 mg/kg in 0.5 ml/kg 
of normal saline or 0.5 ml/kg normal saline only as a placebo, after induction 
and intubation. All patients were induced with thiopentone sodium 3-5 mg/kg, 
succinyl choline 1.5 mg/kg and fentanyl 2 mcg/kg and the drug was given 1 
minute before pneumoperitoneum. Anaesthesia was maintained with nitrous 
oxide, oxygen and sevoflurane. The monitors used were pulseoximeter, 
capnogram, ECG and NIBP. Neuromuscular monitoring was done using train of 
four to watch for any prolongation of neuromuscular blockade. 
The systolic blood pressure, diastolic blood pressure and heart rate were 
monitored throughout the surgery. Intraoperative fentanyl requirements were 
also noted in both groups. The sedation scores, any signs of hypermagnesemia 
and serum magnesium levels were monitored in the postoperative period. 
 Hemodynamic stability is defined as heart rate between 60 and 100 and blood 
pressure fall or rise not more than 15% from the baseline.  
Magnesium sulphate group was found to have a better hemodynamic stability 
than the control group. There was no significant adverse effect observed.  
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CONCLUSION 
Hemodynamic changes during laparoscopic surgeries is a very commonly 
observed event. Various pharmacological agents have been used for stress 
attenuation during laparoscopy. Magnesium sulphate, though used to control 
stress response during intubation, is not a commonly used agent during 
laparoscopy. I decided to study the effect of magnesium sulphate in maintaining 
stable intraoperative hemodynamics during laparoscopic surgeries.  
 
In all patients, premedication and induction was done using standardised drugs. 
Magnesium sulphate 50 mg/kg was given 1 minute before the creation of 
pneumoperitoneum, as a slow intravenous infusion. The control group was 
given an infusion of normal saline. The hemodynamic parameters that were 
monitored intraoperatively include the systolic blood pressure, diastolic blood 
pressure and heart rate.  
 
The observations show that magnesium sulphate produces better intraoperative 
hemodynamics during laparoscopic surgeries.  
 
I conclude that magnesium sulphate is an effective and cheap alternative to 
maintain good hemodynamic stability during laparoscopic surgeries.  
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List of Abbreviations Used 
 
ASA  American societies of Anesthesiologists 
CBF  Cerebral blood flow 
CNS  Central nervous system 
CSF  Cerebrospinal fluid 
GI  Gastrointestinal 
CVS  Cardiovascular system 
ICP  Intra cranial pressure 
IM  Intramuscular 
IV  Intravenous 
PONV  Post operative nausea vomiting 
SVR  Systemic vascular resistance 
IAP  intra abdominal pressure 
H1& H2  Histamine receptors 1 and 2 
5HT₃  5 Hydroxy Tryptamine 
EtCO₂  End tidal carbon dioxide 
TOF  Train of four 
ECG  Electrocardiogram 
NIBP  Non invasive blood pressure 
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Proforma 
 
MAGNESIUM SULPHATE ATTENUATES ARTERIAL PRESSURE INCREASE DURING LAPAROSCOPIC 
SURGERY 
 
NAME:                                           AGE:         SEX:         I.P. NO:                       WARD NO: 
 
HT:                         WT:                                                  ASA:                            
 
DIAGNOSIS:                                                                  PROCEDURE: 
 
GROUP:   M ( magnesium sulphate )  / C (control )  
 
PRE MEDICATION: 
INDUCTION AGENT: 
INTUBATION: 
MAINTAINANCE: 
TOTAL FENTANYL GIVEN:                  
I.V. FLUIDS: 
 
GROUP M: 
Magnesium sulphate 50 mg/kg in 0.5 ml/kg  normal saline  given I.V over 2‐3 min. immediately  
before pneumoperitoneum . 
GROUP C: 
0.5 ml/kg normal saline over 2‐3 min. 
 
   
BASELINE 
 
0 min 
 
5 min 
 
10 min 
 
15 min 
 
20 min 
 
30 min 
 
45 min 
 
60 min 
 
SpO2 
                 
 
HR 
                 
 
SBP 
                 
 
DBP 
                 
 
MAP 
                 
 
OTHER OBSERVATIONS: 
Presence of lacrimation, sweating, eye movement 
Somatic responses‐swallowing, grimacing, coughing, eye opening 
 
INCIDENCE OF BRADYCARDIA OR HYPOTENSION: 
Treatment given: 
97 
 
 
OTHER SIGNIFICANT EVENTS: 
 
 
 
REVERSAL AND EXTUBATION: 
 
 
 
POST OP: 
 
 
 
 
SERUM MAGNESIUM LEVEL: 
 
 
EXCLUSION CRITERIA: 
‐hypermagnesemia 
‐allergy to magnesium sulphate 
‐heart block 
‐diabetes mellitus 
‐hypertension 
‐Cardiovascular or kidney disease 
‐endocrine or metabolic disease 
‐Need for antihypertensives  during surgery  
‐duration of surgery less  than 30 min. 
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Magnesium Group 
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Control Group 
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